Anthony S. Wierzbicki

Citado por

	Total	Desde 2016
Citas	12190	4179
Índice h	58	31
Índice i10	211	91

880

440

220

660

19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202130 65 115 163 177 298 311 369 445 474 526 548 573 615 650 786 811 776 875 857 790 780 842 29

Coautores

Tim ReynoldsDirección de correo verificada de ynolds.org.uk
Tim HardmanNiche Science & Technology LtdDirección de correo verificada de niche.org.uk
Matthew D. LloydSenior Lecturer (Associate Professor) of Pharmacy & Pharmacology, University of Bath, United KingdomDirección de correo verificada de bath.ac.uk
Samuel GiddingA. I. duPont Hospital for ChildrenDirección de correo verificada de nemours.org
Raul D. SantosUniversity of Sao Paulo School of Medicine and Hospital Israelita Albert EinsteinDirección de correo verificada de incor.usp.br
Emanuel ChristProfessor of Endocrinology, University Hospital of BaselDirección de correo verificada de usb.ch
David GoldsmithEmeritus Guy's and St Thomas' Hospitals NHS Foundation TrustDirección de correo verificada de solascure.com
Athyros VEmeritus Professor of Internal Medicine Aristotelian University, Thessaloniki, GreeceDirección de correo verificada de med.auth.gr
David R SullivanClinical Associate Professor, University of SydneyDirección de correo verificada de sydney.edu.au
William Virgil BrownNational Lipid AssociationDirección de correo verificada de lipid.org
Michael MarberProfessor of CardiologyDirección de correo verificada de kcl.ac.uk
Gerbert A. JansenPostdoctoral fellow, Academic Medical Center - University of AmsterdamDirección de correo verificada de amc.uva.nl
Joshua W. KnowlesAssistant Professor, StanfordDirección de correo verificada de stanford.edu
Daniel J RaderProfessor of Medicine, University of PennsylvaniaDirección de correo verificada de mail.med.upenn.edu
Sarah de FerrantiAssociate Professor of Pediatric Cardiology, Boston Children's HospitalDirección de correo verificada de cardio.chboston.org
HR WaterhamProfessor Functional Genetics of Metabolic Diseases at University of AmsterdamDirección de correo verificada de amc.uva.nl
Jackie de BellerocheProfessor of Neuroscience, Imperial College LondonDirección de correo verificada de imperial.ac.uk
Evangelos LiberopoulosUniversity of IoanninaDirección de correo verificada de uoi.gr
Albert FerroProfessor of Cardiovascular Clinical Pharmacology, King's College LondonDirección de correo verificada de kcl.ac.uk
Prof. Manfredi Rizzo, MD, PhDDIBIMIS, University of Palermo, Italy; School of Medicine, University of South Carolina, USADirección de correo verificada de unipa.it

Anthony S. Wierzbicki

Consultant (Honorary Professor) in Metabolic Medicine, Guy's & St Thomas' Hospitals London UK

Dirección de correo verificada de kcl.ac.uk

Cholesterol triglyceride lipids cardiovascular risk peroxisome


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association SS Gidding, M Ann Champagne, SD de Ferranti, J Defesche, MK Ito, ... Circulation 132 (22), 2167-2192, 2015	403	2015
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... International journal of cardiology 171 (3), 309-325, 2014	401	2014
Homocysteine and cardiovascular disease: a review of the evidence AS Wierzbicki Diabetes and Vascular Disease Research 4 (2), 143-149, 2007	347	2007
The lipid and non-lipid effects of statins AS Wierzbicki, R Poston, A Ferro Pharmacology & therapeutics 99 (1), 95-112, 2003	317	2003
“European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ... Current vascular pharmacology 9 (5), 533-571, 2011	273	2011
Familial hypercholesterolaemia: summary of NICE guidance AS Wierzbicki, SE Humphries, R Minhas Bmj 337, 2008	265	2008
Familial hypercholesterolaemia JC Defesche, SS Gidding, M Harada-Shiba, RA Hegele, RD Santos, ... Nature reviews Disease primers 3 (1), 1-20, 2017	259	2017
Relation of erectile dysfunction to angiographic coronary artery disease H Solomon, JW Man, AS Wierzbicki, G Jackson The American journal of cardiology 91 (2), 230-231, 2003	258	2003
Multiple actions of high-density lipoprotein M Florentin, EN Liberopoulos, AS Wierzbicki, DP Mikhailidis Current opinion in cardiology 23 (4), 370-378, 2008	245	2008
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection ER Pearson, S Pruhova, CJ Tack, A Johansen, HAJ Castleden, PJ Lumb, ... Diabetologia 48 (5), 878-885, 2005	241	2005
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance S Rabar, M Harker, N O’Flynn, AS Wierzbicki Bmj 349, g4356, 2014	236	2014
Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial T Marteau, V Senior, SE Humphries, M Bobrow, T Cranston, MA Crook, ... American journal of medical genetics Part A 128 (3), 285-293, 2004	197	2004
Statin-fibrate combination therapy for hyperlipidaemia: a review AS Wierzbicki, DP Mikhailidis, R Wray, M Schachter, R Cramb, ... Current medical research and opinion 19 (3), 155-168, 2003	194	2003
Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation AS Wierzbicki, MD Lloyd, CJ Schofield, MD Feher, FB Gibberd Journal of neurochemistry 80 (5), 727-735, 2002	181	2002
Identification of PEX7 as the second gene involved in Refsum disease DM Van Den Brink, P Brites, J Haasjes, AS Wierzbicki, J Mitchell, ... The American Journal of Human Genetics 72 (2), 471-477, 2003	161	2003
Polymorphisms in the P450 c17 (17-hydroxylase/17, 20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in … J Somner, S McLellan, J Cheung, YT Mak, ML Frost, KM Knapp, ... The Journal of Clinical Endocrinology & Metabolism 89 (1), 344-351, 2004	138	2004
α‐Methylacyl‐CoA racemase–an ‘obscure’metabolic enzyme takes centre stage MD Lloyd, DJ Darley, AS Wierzbicki, MD Threadgill The FEBS Journal 275 (6), 1089-1102, 2008	130	2008
Effect of atorvastatin on plasma fibrinogen. AS Wierzbicki, PJ Lumb, YK Semra, MA Crook Lancet (London, England) 351 (9102), 569, 1998	125	1998
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... Journal of Clinical Lipidology 8 (2), 148-172, 2014	121	2014
Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management Scientific Steering Committee on behalf of the Simon Broome Register Group Atherosclerosis 142 (1), 105-112, 1999	113*	1999

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Subir PDF

Seguir a este autor

Citado por

Coautores